BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32061097)

  • 1. Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki disease.
    Liu FF; Liu HH; Qiu Z; Wang JJ; Samadli S; Wu Y; Wu YF; Xu Y; Luo HH; Chen WX; Zhang DD; Hu P
    Eur J Clin Invest; 2020 Apr; 50(4):e13210. PubMed ID: 32061097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Wu Y; Liu FF; Xu Y; Wang JJ; Samadli S; Wu YF; Liu HH; Chen WX; Luo HH; Zhang DD; Wei W; Hu P
    Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.
    Samadli S; Liu FF; Mammadov G; Wang JJ; Liu HH; Wu YF; Luo HH; Wu Y; Chen WX; Zhang DD; Wei W; Hu P
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):53. PubMed ID: 31366406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoronary inflammation in Kawasaki disease is associated with abnormal myocardial deformation in the acute phase.
    Gaur L; Waloff K; Schiller O; Sable CA; Frank LH
    J Am Soc Echocardiogr; 2014 Dec; 27(12):1329-35. PubMed ID: 25479899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
    Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valvular regurgitation in patients with Kawasaki disease and in healthy children: a pulsed Doppler echocardiographic study].
    Akagi T; Inoue O; Ohara N; Toyoda O; Rikitake N; Mikajima T; Suzuki K; Kato H
    J Cardiol; 1989 Sep; 19(3):787-96. PubMed ID: 2641773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
    Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
    Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission.
    Lin YJ; Lin IC; Yu HR; Kuo HC; Yang KD; Chang WC; Liang CD; Liu SF; Kuo HC
    Pediatr Cardiol; 2013 Feb; 34(2):250-5. PubMed ID: 22810044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.
    Sun Y; Liu J; Geng Z; Tao Y; Zheng F; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2020 Mar; 18(1):23. PubMed ID: 32183825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of echocardiographic evidence of pericardial effusion and mitral regurgitation during the acute stage in predicting development of coronary arterial aneurysms in the late stage of Kawasaki disease.
    Gidding SS; Duffy CE; Pajcic S; Berdusis K; Shulman ST
    Am J Cardiol; 1987 Jul; 60(1):76-9. PubMed ID: 3604947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kawasaki disease in Iceland 1996-2005, epidemiology and complications].
    Olafsdottir HS; Oskarsson G; Haraldsson Á
    Laeknabladid; 2012 Feb; 98(2):91-5. PubMed ID: 22314510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between maternal age and outcomes in Kawasaki disease patients.
    Huang WD; Lin YT; Tsai ZY; Chang LS; Liu SF; Lin YJ; Kuo HC
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):46. PubMed ID: 31324255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septated pericarditis associated with Kawasaki disease: a brief case report.
    Sonçaği A; Devrim I; Karagöz T; Dilber E; Celiker A; Ozen S; Seçmeer G
    Turk J Pediatr; 2007; 49(3):312-4. PubMed ID: 17990588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial).
    Tremoulet AH; Jain S; Kim S; Newburger J; Arditi M; Franco A; Best B; Burns JC
    Contemp Clin Trials; 2016 May; 48():70-5. PubMed ID: 27080929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
    Wang J; Chen H; Shi H; Zhang X; Shao Y; Hang B; Xu Z; Rong X; Chu M; Qiu H
    Pediatr Rheumatol Online J; 2020 Jun; 18(1):48. PubMed ID: 32527316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.